ISBN: 9781617796357
Much work over the last two decades has firmly established that loss of cell cycle checkpoint regulation, and resultant unabated cellular proliferation, is an inherent characteristic of c… Más…
Indigo.ca new in stock. Gastos de envío:zzgl. Versandkosten., más gastos de envío Details... |
ISBN: 9781617796357
Much work over the last two decades has firmly established that loss of cell cycle checkpoint regulation, and resultant unabated cellular proliferation, is an inherent characteristic of c… Más…
Orellfuessli.ch Nr. A1020233954. Gastos de envío:Lieferzeiten außerhalb der Schweiz 3 bis 21 Werktage, , Versandfertig innert 6 - 9 Werktagen, zzgl. Versandkosten. (EUR 17.60) Details... |
ISBN: 9781617796357
Much work over the last two decades has firmly established that loss of cell cycle checkpoint regulation, and resultant unabated cellular proliferation, is an inherent characteristic of c… Más…
Indigo.ca new in stock. Gastos de envío:zzgl. Versandkosten., más gastos de envío Details... |
ISBN: 9781617796357
Paperback, [PU: Humana Press Inc.], This loss may occur through aberration in any single component involved in signal transduction pathways that orchestrate checkpoint regulation, which m… Más…
BookDepository.com Gastos de envío:Versandkostenfrei. (EUR 0.00) Details... |
2012, ISBN: 1617796352
2009 Kartoniert / Broschiert Pharmakologie, BRCA; DNA; cancerresearch; cancertherapy; Cell; celldeath; leukemia; Lymphoma; ovariancancer; Research; Resistance; tumor, mit Schutzumschlag… Más…
Achtung-Buecher.de MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien Gastos de envío:Versandkostenfrei innerhalb der BRD. (EUR 0.00) Details... |
Checkpoint Controls and Targets in Cancer Therapy by Zahid H. Siddik Paperback | Indigo Chapters - libro nuevo
ISBN: 9781617796357
Much work over the last two decades has firmly established that loss of cell cycle checkpoint regulation, and resultant unabated cellular proliferation, is an inherent characteristic of c… Más…
ISBN: 9781617796357
Much work over the last two decades has firmly established that loss of cell cycle checkpoint regulation, and resultant unabated cellular proliferation, is an inherent characteristic of c… Más…
ISBN: 9781617796357
Much work over the last two decades has firmly established that loss of cell cycle checkpoint regulation, and resultant unabated cellular proliferation, is an inherent characteristic of c… Más…
ISBN: 9781617796357
Paperback, [PU: Humana Press Inc.], This loss may occur through aberration in any single component involved in signal transduction pathways that orchestrate checkpoint regulation, which m… Más…
2012, ISBN: 1617796352
2009 Kartoniert / Broschiert Pharmakologie, BRCA; DNA; cancerresearch; cancertherapy; Cell; celldeath; leukemia; Lymphoma; ovariancancer; Research; Resistance; tumor, mit Schutzumschlag… Más…
Datos bibliográficos del mejor libro coincidente
Detalles del libro - Checkpoint Controls and Targets in Cancer Therapy by Zahid H. Siddik Paperback | Indigo Chapters
EAN (ISBN-13): 9781617796357
ISBN (ISBN-10): 1617796352
Tapa blanda
Año de publicación: 2012
Editorial: Zahid H. Siddik
288 Páginas
Peso: 0,544 kg
Idioma: Englisch
Libro en la base de datos desde 2008-07-30T08:40:12-05:00 (Mexico City)
Página de detalles modificada por última vez el 2022-10-07T12:29:45-05:00 (Mexico City)
ISBN/EAN: 1617796352
ISBN - escritura alterna:
1-61779-635-2, 978-1-61779-635-7
Mode alterno de escritura y términos de búsqueda relacionados:
Título del libro: checkpoint
Datos del la editorial
Autor: Zahid H. Siddik
Título: Cancer Drug Discovery and Development; Checkpoint Controls and Targets in Cancer Therapy
Editorial: Humana; Humana Press
274 Páginas
Año de publicación: 2012-03-07
Totowa; NJ; US
Impreso en
Peso: 0,552 kg
Idioma: Inglés
160,49 € (DE)
164,99 € (AT)
177,00 CHF (CH)
POD
XIV, 274 p. 43 illus., 13 illus. in color.
BC; Cancer Research; Hardcover, Softcover / Medizin/Nichtklinische Fächer; Onkologie; Verstehen; BRCA; DNA; cancer; cancer research; cancer therapy; cell; cell death; leukemia; lymphoma; ovarian cancer; research; resistance; tumor; Oncology; Pharmacology/Toxicology; Cancer Biology; Oncology; Pharmacology; Pharmakologie; BB
Part I: Circuitry of Checkpoint Response Chapter 1 G1/S Checkpoint in Normal and Cancer Cells (Bartek J, Copenhagen, Denmark) Chapter 2 S-Phase Checkpoint (Bunz F, Baltimore, MD) Chapter 3 G2/M Checkpoint (Stark GR, Cleveland, OH OR Lukas J, Copenhagen, Denmark) Chapter 4 Mitotic Spindle Checkpoint (Hoffman I, Heidelberg, Germany) Chapter 5 ATM/Chk2 and ATR/Chk1 Pathways (Dunphy WG, Pasadena, CA OR Kastan MB, Memphis, TN) Chapter 7 INK/CIP inhibitor family members (Xiong Y, Chapel Hill, NC OR Rudolph KL, Hannover, Germany) Chapter 8 Centrosome in Checkpoint Response (Muschel RJ, Philadelphia, PA OR Kramer A, Heidelberg, Germany) Chapter 9 14-3-3 Family in Checkpoint Response (Lee M-H, Houston, TX OR Hermeking H, Munich, Germany) Chapter 10 BRCA1/2 in Checkpoint (Deng CX, Bethesda, MD OR Boulton SJ, South Mimms, UK) Chapter 11 Regulation of Checkpoint Response by CDC25 (Ducommun R, Toulouse, France) Chapter 12 DNA Damage Recognition in Checkpoint Response (Marini F, Milano, Italy) Part II: Checkpoint Response and the Aetiology of Cancer Chapter 13 Checkpoint Response and Cancer (Nakanishi M, Nagoya, Japan OR Mollinari M, Milan, Italy) Chapter 14 G1-Phase Cyclins and Cancer (Hinds PW, Boston, MA OR Keyomarsi K, Houston, TX) Chapter 15 Tumor Suppressor p53 and Cancer (El-Deiry WS, Philadelphia, PA OR Zambetti GP, Memphis, TN) Chapter 16 Rb dysfunction and Cancer (Giordano A, Philadelphia, PA) Chapter 17 Chk2 Status in Cancer (Nevanlinna H, Helsinki, Finland) Chapter 18 BRCA1/2 in Cancer (Borgen PI, New York, NY) Part III: Targeting Checkpoint Response in Cancer Therapy Chapter 19 Checkpoint Response and the Balance Between Cell Survival and Cell Death (Kaina B, Mainz, Germany OR Saito T, Tochigi, Japan) Chapter 20 Targeting p53 for checkpoint activation (Eastman A, Lebanon, NH OR Giardina C, Storrs, CT Chapter 21 Targeting Checkpoint Kinases with Small molecule inhibitors (Shapiro GI, Boston, MA OR Toogood PL, Ann Arbor, MI) Chapter 22 p21-Dependent Checkpoint Response and Therapy (Siddik ZH, Houston, TX) Chapter 23 p27 Upregulation as a Target for Therapy-Mediated Cell Death (Bast R, Houston, TX OR Malek NP, Hannover, Germany) Chapter 24 Chk1/Chk2 as checkpoint targets (Zhang H, Abbott Park, IL OR Grant S, Richmond) Chapter 25 Mitotic Spindle Checkpoint as a Target (Taylor SS, Manchester, UK OR Jackson JR, Collegeville, PA) Chapter 26 Targeting Cdc25 in cancer therapy (Rudolph J, Durham, NC)Más, otros libros, que pueden ser muy parecidos a este:
Último libro similar:
9781607611776 Checkpoint Controls and Targets in Cancer Therapy by Zahid H. Siddik Hardcover | Indigo Chapters (Zahid H. Siddik)
< para archivar...